Zechmann Stefan, Senn Oliver, Valeri Fabio, Neuner-Jehle Stefan, Rosemann Thomas, Djalali Sima
Institute of Primary Care, University of Zurich, University Hospital Zurich, Zurich, Switzerland.
J Clin Hypertens (Greenwich). 2017 May;19(5):510-518. doi: 10.1111/jch.12958. Epub 2017 Jan 6.
Previous studies suggest that up to 60% of all patients with hypertension receive inappropriate treatment. Current 2013 European Society of Hypertension/European Society of Cardiology (ESH/ESC) guidelines recommend taking cardiovascular risk factors into account when assessing treatment for patients with hypertension. The authors hypothesize that this approach will reduce the proportion of patients receiving inappropriate treatment. In this cross-sectional study using electronic medical records of Swiss primary care patients, the authors estimate the proportion of patients receiving inappropriate treatment using two approaches: (1) based on a blood pressure threshold of 140/90 mm Hg; and (2) based on cardiovascular risk factors. A total of 22 434 patients with hypertension were identified. Based on these approaches, 72.7% and 44.6% of patients, respectively, qualified for drug treatment. In addition, 23.0% and 10.8% of patients, respectively, received inappropriate treatment. Application of the 2013 ESH/ESC guidelines reduced the proportion of patients receiving inappropriate treatment by 50%. This shows the major impact of risk adjustment and highlights the need for a patient-centered approach in hypertension treatment.
以往研究表明,高达60%的高血压患者接受了不恰当的治疗。2013年欧洲高血压学会/欧洲心脏病学会(ESH/ESC)现行指南建议,在评估高血压患者的治疗方案时应考虑心血管危险因素。作者推测,这种方法将降低接受不恰当治疗的患者比例。在这项使用瑞士初级保健患者电子病历的横断面研究中,作者采用两种方法估计接受不恰当治疗的患者比例:(1)基于140/90 mmHg的血压阈值;(2)基于心血管危险因素。共识别出22434例高血压患者。基于这些方法,分别有72.7%和44.6%的患者符合药物治疗条件。此外,分别有23.0%和10.8%的患者接受了不恰当治疗。应用2013年ESH/ESC指南使接受不恰当治疗的患者比例降低了50%。这显示了风险调整的重大影响,并突出了高血压治疗中以患者为中心方法的必要性。